...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.
【24h】

Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.

机译:介导18-MC对甲基苯丙胺和蔗糖自我给药的α3beta4烟碱类拮抗剂作用的大脑区域。

获取原文
获取原文并翻译 | 示例
           

摘要

The novel iboga alkaloid congener 18-methoxycoronaridine (18-MC) is a putative anti-addictive agent that has been shown, in rats, to decrease the self-administration of several drugs of abuse. Previous work has established that 18-MC is a potent antagonist at alpha3beta4 nicotinic receptors. Because high densities of alpha3beta4 nicotinic receptors occur in the medial habenula and the interpeduncular nucleus and moderate densities occur in the dorsolateral tegmentum, ventral tegmental area, and basolateral amygdala, the present study was conducted to determine if 18-MC could act in these brain areas to modulate methamphetamine self-administration in rats. Local administration of 18-MC into either the medial habenula, the interpeduncular area or the basolateral amygdala decreased methamphetamine self-administration. Similar results were produced by local administration into the same brain areas of two other alpha3beta4 nicotinic antagonists, mecamylamine and alpha-conotoxin AuIB. Local administration of18-MC, or the other antagonists, into the dorsolateral tegmentum or the ventral tegmental area had no effect on methamphetamine self-administration. In contrast, local administration of 18-MC and the other antagonists decreased sucrose self-administration when administered into the dorsolateral tegmentum or basolateral amygdala but had no effect when infused into the medial habenula, interpeduncular nucleus, or ventral tegmental area. These data are consistent with the hypothesis that 18-MC decreases methamphetamine self-administration by indirectly modulating the dopaminergic mesolimbic pathway via blockade of alpha3beta4 nicotinic receptors in the habenulo-interpeduncular pathway and the basolateral amygdala. The data also suggest that the basolateral amygdala along with a different pathway involving alpha3beta4 receptors in the dorsolateral tegmentum mediate the effect of 18-MC on sucrose self-administration.
机译:新型的伊博加生物碱同类物18-甲氧基冠心氨酸(18-MC)是一种推定的抗成瘾剂,已在大鼠中显示出减少几种滥用药物的自我给药的作用。先前的工作已经确定18-MC是α3beta4烟碱受体的有效拮抗剂。由于高密度的α3β4烟碱受体发生在内侧ha管中,而椎弓根间核和中密度发生在背外侧被膜,腹侧被盖区和基底外侧杏仁核,因此,本研究旨在确定18-MC是否可以在这些脑区起作用调节大鼠体内的甲基苯丙胺自我管理。将18-MC局部给药至内侧哈贝纳,足突间区或基底外侧杏仁核可降低甲基苯丙胺的自我给药。通过局部施用于其他两种alpha3beta4烟碱类拮抗剂美卡明胺和α-芋螺毒素AuIB的相同大脑区域也产生了相似的结果。在背外侧被盖或腹侧被盖区域局部施用18-MC或其他拮抗剂对甲基苯丙胺的自用没有影响。相比之下,当将18-MC和其他拮抗剂局部给药于背外侧被膜或基底外侧杏仁核时,蔗糖的自我给药会降低,但输注至内侧ha,椎间盘核或腹侧被膜区域则无效。这些数据与以下假设相符:18-MC通过阻断哈贝努洛-人间足通路和基底外侧杏仁核中的α3β4烟碱受体间接调节多巴胺能中脑边缘通路,从而减少了甲基苯丙胺的自我给药。数据还表明,基底外侧杏仁核以及涉及背外侧被膜中α3β4受体的不同途径介导了18-MC对蔗糖自我给药的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号